These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8583235)

  • 1. Studies of dementia, depression, electrophysiology and cerebrospinal fluid monoamine metabolites in patients with Parkinson's disease.
    Chia LG; Cheng LJ; Chuo LJ; Cheng FC; Cu JS
    J Neurol Sci; 1995 Nov; 133(1-2):73-8. PubMed ID: 8583235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual and auditory evoked potentials in early onset Parkinson's disease and their relationship to cerebrospinal fluid monoamine metabolites.
    Muthane UB; Satishchandra P; Subhash MN
    Mov Disord; 1993 Jul; 8(3):344-8. PubMed ID: 7688076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamines and their metabolites in plasma and lumbar cerebrospinal fluid of Chinese patients with Parkinson's disease.
    Chia LG; Cheng FC; Kuo JS
    J Neurol Sci; 1993 Jun; 116(2):125-34. PubMed ID: 8336158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual and somatosensory evoked potentials in Parkinson's and Binswanger's disease.
    Okuda B; Tachibana H; Takeda M; Kawabata K; Sugita M
    Dementia; 1996; 7(1):53-8. PubMed ID: 8788083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-latency somatosensory and brainstem auditory evoked potentials in patients with Parkinson's disease.
    Tachibana H; Takeda M; Sugita M
    Int J Neurosci; 1989 Feb; 44(3-4):321-6. PubMed ID: 2722418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease. Clinical and electrophysiological evaluation.
    Al-Bunyan MA
    Saudi Med J; 2000 Jan; 21(1):72-5. PubMed ID: 11533754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson's disease.
    Compta Y; Valente T; Saura J; Segura B; Iranzo Á; Serradell M; Junqué C; Tolosa E; Valldeoriola F; Muñoz E; Santamaria J; Cámara A; Fernández M; Fortea J; Buongiorno M; Molinuevo JL; Bargalló N; Martí MJ
    J Neurol; 2015 Feb; 262(2):294-306. PubMed ID: 25380583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age and stage dependency of P300 latency alterations in non-demented Parkinson's disease patients without therapy.
    Stanzione P; Semprini R; Pierantozzi M; Santilli AM; Fadda L; Traversa R; Peppe A; Bernardi G
    Electroencephalogr Clin Neurophysiol; 1998 Jan; 108(1):80-91. PubMed ID: 9474065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatosensory amplification and its relationship to somatosensory, auditory, and visual evoked and event-related potentials (P300).
    Nakao M; Barsky AJ; Nishikitani M; Yano E; Murata K
    Neurosci Lett; 2007 Mar; 415(2):185-9. PubMed ID: 17267120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Event-related potential and visual evoked potential in patients with Parkinson's disease].
    Takeda M; Tachibana H; Okuda B; Kawabata K; Sugita M
    Nihon Ronen Igakkai Zasshi; 1993 May; 30(5):363-8. PubMed ID: 8331829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of the postexcitatory cortical inhibition upon paired-click auditory stimulation in patients with Parkinson's disease.
    Lukhanina EP; Kapustina MT; Berezetskaya NM; Karaban IN
    Clin Neurophysiol; 2009 Oct; 120(10):1852-8. PubMed ID: 19767236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain-related somatosensory evoked potentials in dementia.
    Yamamoto M; Kachi T; Igata A
    J Neurol Sci; 1996 May; 137(2):117-9. PubMed ID: 8782164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auditory event-related potentials in Parkinson's disease: prominent correlation with attention.
    Matsui H; Nishinaka K; Oda M; Kubori T; Udaka F
    Parkinsonism Relat Disord; 2007 Oct; 13(7):394-8. PubMed ID: 17329143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evoked potentials in parkinsonism].
    Sadekov RA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(4):64-5. PubMed ID: 9214195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation of visual evoked potentials with dementia in Parkinson's disease].
    Okuda B; Tachibana H; Kawabata K; Takeda M; Toda K; Sugita M
    Nihon Ronen Igakkai Zasshi; 1992 Jun; 29(6):475-9. PubMed ID: 1527904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Parkinson disease and cognitive evoked potentials].
    Gil R; Neau JP; Toullat G; Rivasseau-Jonveaux T; Lefèvre JP
    Rev Neurol (Paris); 1989; 145(3):201-7. PubMed ID: 2749097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease, cognition and aging. Clinical, neuropsychological, electrophysiological and cranial computerized tomographic assessment.
    Elwan OH; Baradah OH; Madkour O; Elwan H; Hassan AA; Elwan F; Mahfouz M; Ali A; Fahmy M
    J Neurol Sci; 1996 Nov; 143(1-2):64-71. PubMed ID: 8981300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease--effect of L-Dopa.
    Strittmatter M; Hamann GF; Strubel D; Cramer H; Schimrigk K
    J Neural Transm (Vienna); 1996; 103(5):591-602. PubMed ID: 8811504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vestibulocervical reflexes in idiopathic Parkinson disease.
    Pollak L; Prohorov T; Kushnir M; Rabey M
    Neurophysiol Clin; 2009; 39(4-5):235-40. PubMed ID: 19853795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression in Parkinson's disease: biogenic amines in CSF of "de novo" patients.
    Kuhn W; Müller T; Gerlach M; Sofic E; Fuchs G; Heye N; Prautsch R; Przuntek H
    J Neural Transm (Vienna); 1996; 103(12):1441-5. PubMed ID: 9029411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.